Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Succinylcholine price, strengths & recalls

Succinylcholine has no weekly pharmacy acquisition cost. 23 manufacturers make it. It is in shortage (being discontinued). 4 recalls are ongoing. Its official label last changed on February 10, 2026.

Being discontinued4 open recallsGeneric
No weekly pricePharmacy acquisition costs aren't published for this drug - usually because it's given in clinics or hospitals.

Succinylcholine price by strength

What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
20 mg/mL injectionNot priced this week
20 mg/mL, 10 mL prefilled syringeNot priced this week
20 mg/mL, 5 mL prefilled syringeNot priced this week

Supply status: shortages & recalls

In shortage1 product is short or being discontinued
4 ongoing recalls45 recalls on record, latest Oct 15, 2025

Shortages

  • Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10)Fresenius Kabi USA, LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 45 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for succinylcholine? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedFebruary 10, 2026
Version1
EffectiveJan 21, 2026
Read the label

These highlights do not include all the information needed to use SUCCINYLCHOLINE CHLORIDE INJECTION safely and effectively. See full prescribing information for SUCCINYLCHOLINE CHLORIDE INJECTION.SUCCINYLCHOLINE CHLORIDE injection, for intravenous or intramuscular use Initial U.S. Approval: 1952

This drug has a boxed warning

WARNING: VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH FROM HYPERKALEMIC RHABDOMYOLYSIS IN PEDIATRIC PATIENTS

Acute rhabdomyolysis with hyperkalemia followed by ventricular dysrhythmias, cardiac arrest, and death has occurred after the administration of succinylcholine to apparently healthy pediatric patients who were subsequently found to have undiagnosed skeletal muscle myopathy, most frequently Duchenne muscular dystrophy [see Warnings and Precautions (5.1)].

When a healthy appearing pediatric patient develops cardiac arrest within minutes after administration of Succinylcholine Chloride Injection, not felt to be due to inadequate ventilation, oxygenation or anesthetic overdose, immediate treatment for hyperkalemia should be instituted. In the presence of signs of malignant hyperthermia, appropriate treatment should be instituted concurrently [see Warnings and Precautions (5.1)].

Reserve the use of Succinylcholine Chloride Injection in pediatric patients for emergency intubation or instances where immediate securing of the airway is necessary, e.g., laryngospasm, difficult airway, full stomach, or for intramuscular use when a suitable vein is inaccessible [see Warnings and Precautions (5.1)].

WARNING: VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH FROM HYPERKALEMIC RHABDOMYOLYSIS IN PEDIATRIC PATIENTS

See full prescribing information for complete boxed warning.

Acute rhabdomyolysis with hyperkalemia followed by ventricular dysrhythmias, cardiac arrest, and death has occurred after use in apparently healthy pediatric patients who were subsequently found to have undiagnosed skeletal muscle myopathy. (5.1)

When a healthy-appearing pediatric patient develops cardiac arrest soon after administration of Succinylcholine Chloride Injection, not felt to be due to other causes, immediate treatment for hyperkalemia should be instituted. In the presence of signs of malignant hyperthermia, appropriate treatment should be instituted concurrently. (5.1)

Reserve use of Succinylcholine Chloride Injection in pediatric patients for emergency intubation or instances where immediate securing of the airway is necessary, or for intramuscular use when a suitable vein is inaccessible. (5.1)

Recent major changes (as listed on the label)

Contraindications (4)

| 11/2022 |

Warnings and Precautions, Malignant Hyperthermia (5.5)

| 11/2022 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
19 approved generic applications on the market

Succinylcholine questions

Is succinylcholine in shortage?

Yes. 1 product is listed as in shortage or being discontinued (being discontinued). See which ones.

Has succinylcholine been recalled?

45 recalls on record, 4 ongoing. Recalls name specific lots - check yours.

When did the succinylcholine label last change?

The official label was last updated on February 10, 2026 (version 1). See what changed.

Talk about succinylcholine

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.